RIV Capital Inc CNPOF

Primary Symbol: C.RIV

Financial Services Asset Management

RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC.

CSE:RIV - Post by User

RIV Capital Inc

<< Previous

Bullboard Posts

Next >>

Post by proneon Nov 08, 2023 7:28am

229 Views

Post# 35723050

Just starting to grow faster with strong production....

setup -->

Recently completed expansion of Chestertown facility triples current cannabis production capacity

Enhanced research and development capabilities to drive product innovation

Strongly positioned to become a leading supplier to the New York adult-use cannabis market

RIV Capital today announced that the expansion of its cannabis cultivation and production facility located in Chestertown, New York (the “Chestertown Facility”) is now operational.

The recently completed enhancements at the Chestertown Facility include:

Overall facility footprint expanded to more than 75,000 sq. ft, comprised of:
- High-tech greenhouse cultivation space;
- Lab and manufacturing space;
- Distribution and warehousing space; and
- Finished goods and dry flower storage space.
The implementation of advanced equipment and automation technologies, which significantly improves the Company’s production rate of high-quality flower and extracts.